Menu Search
Equities

Encompass Health Corp

EHC*:MEX

Encompass Health Corp

Actions
  • Price (MXN)897.25
  • Today's Change-0.001 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 29 2021 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Encompass Health Corp grew revenues 10.41% from 4.35bn to 4.80bn while net income improved 29.89% from 271.00m to 352.00m.
Gross margin95.49%
Net profit margin10.80%
Operating margin15.76%
Return on assets9.07%
Return on equity24.50%
Return on investment11.87%
More ▼

Cash flow in USDView more

In 2023, Encompass Health Corp increased its cash reserves by 95.13%, or 50.80m. The company earned 850.80m from its operations for a Cash Flow Margin of 17.72%. In addition the company used 602.80m on investing activities and also paid 197.20m in financing cash flows.
Cash flow per share8.38
Price/Cash flow per share12.10
Book value per share19.45
Tangible book value per share3.77
More ▼

Balance sheet in USDView more

Encompass Health Corp has a Debt to Total Capital ratio of 48.60%, a lower figure than the previous year's 172.56%.
Current ratio1.04
Quick ratio--
Total debt/total equity1.32
Total debt/total capital0.486
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)1.60%
Div growth rate (5 year)-10.42%
Payout ratio (TTM)14.63%
EPS growth(5 years)4.11
EPS (TTM) vs
TTM 1 year ago		19.73
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.